Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kathleen M Fox

Showing results (41-50 of 92) with videos related to

Pageof 10
Sort By:
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|December 24, 2017
Treatment patterns and low-density lipoprotein cholesterol (LDL-C) goal attainment among patients receiving high- or moderate-intensity statinsKathleen M Fox, Ming-Hui Tai, Karel Kostev, et al.
Current Medical Research and Opinion|March 16, 2013
Dosing patterns of three tumor necrosis factor blockers among patients with rheumatoid arthritis in a large United States managed care populationMaxine D Fisher, Crystal Watson, Kathleen M Fox, et al.
Journal of Medical Economics|August 3, 2010
Medical and cost burden of atherosclerosis among patients treated in routine clinical practiceRobert L Ohsfeldt, Sanjay K Gandhi, Kathleen M Fox, et al.
Journal of Oncology|July 10, 2009
Estimation of Cachexia among Cancer Patients Based on Four DefinitionsKathleen M Fox, John M Brooks, Shravanthi R Gandra, et al.
The American Journal of Managed Care|November 23, 2006
Effectiveness and cost-effectiveness of rosuvastatin, atorvastatin, and simvastatin among high-risk patients in usual clinical practiceRobert L Ohsfeldt, Sanjay K Gandhi, Kathleen M Fox, et al.
Journal of Medical Economics|October 18, 2013
National and regional dose escalation and cost of tumor necrosis factor blocker therapy in biologic-naïve rheumatoid arthritis patients in US health plansAmie T Joyce, Shravanthi R Gandra, Kathleen M Fox, et al.
Archives of Physical Medicine and Rehabilitation|February 28, 2006
The Lower Extremity Gain Scale: a performance-based measure to assess recovery after hip fractureSheryl Zimmerman, William G Hawkes, J Richard Hebel, et al.
Clinical Therapeutics|January 31, 2012
Factors associated with the initiation of disease-modifying antirheumatic drugs in newly diagnosed rheumatoid arthritis: a retrospective claims database studyMachaon M K Bonafede, Kathleen M Fox, Barbara H Johnson, et al.
Journal of Clinical Lipidology|February 5, 2011
Medical management of patients before the incidence of a cardiovascular eventMichael H Davidson, Kathleen M Fox, Sanjay K Gandhi, et al.
Advances in Therapy|March 8, 2014
Treatment patterns following discontinuation of adalimumab, etanercept, and infliximab in a US managed care sampleJason Yeaw, Crystal Watson, Kathleen M Fox, et al.
Pageof 10

Showing results (41-50 of 92) with videos related to

Sort By:
Pageof 10
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|December 24, 2017
Treatment patterns and low-density lipoprotein cholesterol (LDL-C) goal attainment among patients receiving high- or moderate-intensity statinsKathleen M Fox, Ming-Hui Tai, Karel Kostev, et al.
Current Medical Research and Opinion|March 16, 2013
Dosing patterns of three tumor necrosis factor blockers among patients with rheumatoid arthritis in a large United States managed care populationMaxine D Fisher, Crystal Watson, Kathleen M Fox, et al.
Journal of Medical Economics|August 3, 2010
Medical and cost burden of atherosclerosis among patients treated in routine clinical practiceRobert L Ohsfeldt, Sanjay K Gandhi, Kathleen M Fox, et al.
Journal of Oncology|July 10, 2009
Estimation of Cachexia among Cancer Patients Based on Four DefinitionsKathleen M Fox, John M Brooks, Shravanthi R Gandra, et al.
The American Journal of Managed Care|November 23, 2006
Effectiveness and cost-effectiveness of rosuvastatin, atorvastatin, and simvastatin among high-risk patients in usual clinical practiceRobert L Ohsfeldt, Sanjay K Gandhi, Kathleen M Fox, et al.
Journal of Medical Economics|October 18, 2013
National and regional dose escalation and cost of tumor necrosis factor blocker therapy in biologic-naïve rheumatoid arthritis patients in US health plansAmie T Joyce, Shravanthi R Gandra, Kathleen M Fox, et al.
Archives of Physical Medicine and Rehabilitation|February 28, 2006
The Lower Extremity Gain Scale: a performance-based measure to assess recovery after hip fractureSheryl Zimmerman, William G Hawkes, J Richard Hebel, et al.
Clinical Therapeutics|January 31, 2012
Factors associated with the initiation of disease-modifying antirheumatic drugs in newly diagnosed rheumatoid arthritis: a retrospective claims database studyMachaon M K Bonafede, Kathleen M Fox, Barbara H Johnson, et al.
Journal of Clinical Lipidology|February 5, 2011
Medical management of patients before the incidence of a cardiovascular eventMichael H Davidson, Kathleen M Fox, Sanjay K Gandhi, et al.
Advances in Therapy|March 8, 2014
Treatment patterns following discontinuation of adalimumab, etanercept, and infliximab in a US managed care sampleJason Yeaw, Crystal Watson, Kathleen M Fox, et al.
Pageof 10